Company: NOTV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023370
Chunk: 125

Company: Inotiv, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 8
Chunk 125
---
 income taxes$(15,976)$(54,443)$(45,784)$(73,765)The following table presents depreciation and amortization and capital expenditures by reportable segment for the three and six months ended March 31, 2025 and 2024:Three Months EndedMarch 31,Six Months EndedMarch 31,2025202420252024Depreciation and amortization: DSA$4,516 $4,363 $9,099 $8,772 RMS9,150 9,643 18,588 19,380   Unallocated Corporate158 149 316 253  $13,824 $14,155 $28,003 $28,405  Capital expenditures:DSA$1,105 929 $1,481 $3,204 RMS4,368 6,093 8,451 9,390  $5,473 $7,022 $9,932 $12,594 Geographic InformationThe following represents revenue originating in entities physically located in the identified geographic area:Three Months EndedMarch 31,Six Months EndedMarch 31,2025202420252024United States$112,151 $102,429 $209,550 $214,198 Netherlands4,603 9,724 20,437 27,786 Other7,569 6,882 14,212 12,552 $124,323 $119,035 $244,199 $254,536 

15

Long-lived assets shown below include property and equipment, net. The following represents long-lived assets where they are physically located:March 31,September 30,20252024United States$161,614 $167,772 Netherlands6,580 7,159 Other12,961 13,397 $181,155 $188,328 

4.    DEBT

Long-term debt as of March 31, 2025 and September 30, 2024 is detailed in the table below. March 31, 2025September 30, 2024Seller Note – Bolder BioPath (Related party)$263 $376 Seller Note – Preclinical Research Services— 464 Seller Payable - Orient BioResource Center3,235 3,700 Seller Note – Histion (Related party)